位置:首页 > 蛋白库 > FTSW_CAUVN
FTSW_CAUVN
ID   FTSW_CAUVN              Reviewed;         390 AA.
AC   B8H092;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   03-AUG-2022, entry version 64.
DE   RecName: Full=Probable peptidoglycan glycosyltransferase FtsW {ECO:0000250|UniProtKB:P39604};
DE            Short=PGT {ECO:0000250|UniProtKB:P39604};
DE            EC=2.4.1.129 {ECO:0000250|UniProtKB:P39604};
DE   AltName: Full=Cell division protein FtsW {ECO:0000250|UniProtKB:O07639};
DE   AltName: Full=Cell wall polymerase {ECO:0000250|UniProtKB:P39604};
DE   AltName: Full=Peptidoglycan polymerase {ECO:0000250|UniProtKB:P39604};
DE            Short=PG polymerase {ECO:0000250|UniProtKB:P39604};
GN   Name=ftsW; OrderedLocusNames=CCNA_02635;
OS   Caulobacter vibrioides (strain NA1000 / CB15N) (Caulobacter crescentus).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Caulobacterales;
OC   Caulobacteraceae; Caulobacter.
OX   NCBI_TaxID=565050;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NA1000 / CB15N;
RX   PubMed=20472802; DOI=10.1128/jb.00255-10;
RA   Marks M.E., Castro-Rojas C.M., Teiling C., Du L., Kapatral V.,
RA   Walunas T.L., Crosson S.;
RT   "The genetic basis of laboratory adaptation in Caulobacter crescentus.";
RL   J. Bacteriol. 192:3678-3688(2010).
RN   [2]
RP   INTERACTION WITH FTSI; FTSN AND SIDA, AND MUTAGENESIS OF PHE-145 AND
RP   THR-180.
RC   STRAIN=NA1000 / CB15N;
RX   PubMed=21685367; DOI=10.1101/gad.2038911;
RA   Modell J.W., Hopkins A.C., Laub M.T.;
RT   "A DNA damage checkpoint in Caulobacter crescentus inhibits cell division
RT   through a direct interaction with FtsW.";
RL   Genes Dev. 25:1328-1343(2011).
CC   -!- FUNCTION: Peptidoglycan polymerase that is essential for cell division.
CC       {ECO:0000250|UniProtKB:P39604}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-
CC         Ala)](n)-di-trans,octa-cis-undecaprenyl diphosphate + beta-D-GlcNAc-
CC         (1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-
CC         cis-undecaprenyl diphosphate = [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-
CC         D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-di-trans-octa-cis-undecaprenyl
CC         diphosphate + di-trans,octa-cis-undecaprenyl diphosphate + H(+);
CC         Xref=Rhea:RHEA:23708, Rhea:RHEA-COMP:9602, Rhea:RHEA-COMP:9603,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58405, ChEBI:CHEBI:60033,
CC         ChEBI:CHEBI:78435; EC=2.4.1.129;
CC         Evidence={ECO:0000250|UniProtKB:P39604};
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC       {ECO:0000250|UniProtKB:P39604}.
CC   -!- SUBUNIT: Interacts with FtsI, FtsN and the cell division inhibitor
CC       SidA. {ECO:0000269|PubMed:21685367}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=Localizes to the division septum.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SEDS family. FtsW subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001340; ACL96100.1; -; Genomic_DNA.
DR   RefSeq; WP_010920409.1; NC_011916.1.
DR   RefSeq; YP_002518008.1; NC_011916.1.
DR   AlphaFoldDB; B8H092; -.
DR   SMR; B8H092; -.
DR   DIP; DIP-61066N; -.
DR   IntAct; B8H092; 2.
DR   PRIDE; B8H092; -.
DR   EnsemblBacteria; ACL96100; ACL96100; CCNA_02635.
DR   GeneID; 7332737; -.
DR   KEGG; ccs:CCNA_02635; -.
DR   PATRIC; fig|565050.3.peg.2583; -.
DR   HOGENOM; CLU_029243_1_1_5; -.
DR   OMA; KLWWSNL; -.
DR   OrthoDB; 1133883at2; -.
DR   PhylomeDB; B8H092; -.
DR   UniPathway; UPA00219; -.
DR   Proteomes; UP000001364; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   InterPro; IPR013437; FtsW.
DR   InterPro; IPR001182; FtsW/RodA.
DR   PANTHER; PTHR30474; PTHR30474; 1.
DR   Pfam; PF01098; FTSW_RODA_SPOVE; 1.
DR   TIGRFAMs; TIGR02614; ftsW; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Cell inner membrane; Cell membrane; Cell shape;
KW   Cell wall biogenesis/degradation; Glycosyltransferase; Membrane;
KW   Peptidoglycan synthesis; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..390
FT                   /note="Probable peptidoglycan glycosyltransferase FtsW"
FT                   /id="PRO_0000420268"
FT   TRANSMEM        27..47
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..80
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        91..111
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        125..145
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..173
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        181..201
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        279..299
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        315..335
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        348..368
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         145
FT                   /note="F->L: Decreases interaction with SidA."
FT                   /evidence="ECO:0000269|PubMed:21685367"
FT   MUTAGEN         180
FT                   /note="T->A: Decreases interaction with SidA."
FT                   /evidence="ECO:0000269|PubMed:21685367"
SQ   SEQUENCE   390 AA;  42014 MW;  282DFE558231AB36 CRC64;
     MASNATHAFA RTDRTALGLW WWTTDRWLLG ATALLVTLGM LLSFASSPAA AQRIGIDDQF
     HFALRMCFFA TASSVLMLIT SMLSPRDIRR AAFFIYLGAI AVMIALPFIG HNAKGATRWL
     QFAGFTLQPS EFMKPALIVL VSWMFAEGQK GEGVPGVSIA FLLYFIAVAL LLIQPDVGQT
     VLITIAFGAA FWMAGVPISW IMGLGGVALA GLGSTYFLFD HVHARVQKFL SPDQADTHQI
     TRAAEAIRAG GLFGRGPGEG VMKRHVPDLH TDFIYSVAAE EYGLIFSWSL IGLFAFVVVR
     GLYKAMKLND PFEQVAAAGL FVLVGQQALI NIAVNLNMIP TKGMTLPFIS YGGSSMLAMG
     LTLGMALALL RKRPGAYGAS GEFGFGRADA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024